Changing lives through medical technology

Lifecare develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers.

Lifecare as an investment

Lifecare is dedicated to developing the next generation of miniaturized and implantable long-term sensors. We have a particular focus on diabetes and are dedicated towards helping the more than 500 million people living with diabetes. Lifecare AS is listed on Euronext Oslo Børs with ticker “LIFE”.

Investor

NOK –

Last updated 1970-01-01 00:00:00

Change +0.00

Volume 0,000

High 0.00 NOK

Low 0.00 NOK

Technology

Nanontechnology for medical use

Lifecare develops and licenses nanotechnology for medical use, to facilitate the production and sale of medical devices. Our own miniaturized sensor technology measures changes by reading osmotic pressure variations in a small chamber. It has several use cases and can e.g. measure glucose and lactate levels by applying different chemical compositions.

Solutions

Improving lives for diabetes patients

Today, people with diabetes are dependent on painful and time-consuming glucose measurement procedures based on a more than 40-year-old technology. Our aim is to help people and pets with diabetes to live a normal life enabled by a glucose sensor at the size of a grain of rice – called Sencell – that continuously measures glucose levels for longer time periods than currently existing devices.

About

Our company

Our headquarter is located in Bergen, Norway while our research and development activities are performed in Mainz and Reutlingen in Germany. We have a chemistry lab in Bristol, UK. We have ongoing development projects with partners across Europe.